Keshia Kroh

Keshia Kroh

Auto-generated profile, based on publicly available information

Keshia Kroh

Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
PPPraveen Papareddy
Praveen Papareddy
ITInes Tapken
Ines Tapken
KKKeshia Kroh
Keshia Kroh
RBRavi Kiran Varma Bhongir
Ravi Kiran Varma Bhongir
Milladur RahmanMilladur Rahman
Milladur Rahman
HHHeiko Herwald
Heiko Herwald
Extracellular vesicles (EVs) play a crucial role in intercellular communication by transferring bioactive molecules from donor to recipient cells. As a result, EV fusion leads to the modulation of cellular functions and has an impact on both physiological and pathological processes in the recipient cell. This study explores the impact of EV fusion on cellular responses to inflammatory signaling. Our findings reveal that fusion renders non-responsive cells susceptible to inflammatory signaling, as evidenced by increased NF-κB activation and the release of inflammatory mediators. Syntaxin-binding protein 1 is essential for the merge and activation of intracellular signaling. Subsequent analysis show that EVs transfer their functionally active receptors to target cells, making them prone to an otherwise unresponsive state. EVs in complex with their agonist, require no further stimulation of the target cells to trigger mobilization of NF-κB. While receptor antagonists were unable to inhibit NF-κB activation, blocking of the fusion between EVs and their target cells with heparin mitigated inflammation in mice challenged with EVs.

16 April 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
KKKeshia Kroh
Keshia Kroh
ABAlisha D. Biharie
Alisha D. Biharie
EMEleanor Margaret Marshall
Eleanor Margaret Marshall
RRRedwan Rahmat
Redwan Rahmat
DSDebby Schipper
Debby Schipper
CECarmen Embregts
Carmen Embregts
Rabies is a fatal zoonotic infection caused by rabies virus (RABV), which is transmitted through the saliva of infected animals. Although most cases are caused by dog bites, superficial exposures such as bat bites or scratches can also lead to infection, although the underlying mechanisms remain poorly understood. We recently detected RABV-positive keratinocytes in skin samples of experimentally infected mice and naturally infected dogs, prompting us to investigate their role in rabies pathogenesis and the antiviral immune response. We confirmed that both the keratinocyte cell line HaCaT and primary keratinocytes are susceptible to RABV infection in vitro, with higher infection rates observed for the attenuated SAD P5/88 Potsdam and silver-haired bat RABV strains than for a dog-related strain. Keratinocytes showed a significant immune activation in response to these 2 strains, as measured by expression of relevant surface markers and cytokine release. To explore whether RABV can be transmitted from infected keratinocytes to neurons, we developed a coculture model using HaCaT and a neuronal cell line separated by a microporous membrane. Virus transfer to the neurons was observed while the barrier integrity remained intact, suggesting that keratinocytes may contribute to RABV transmission and neuroinvasion after superficial exposure.

6 November 2025 in Journal of General Virology
Verified
Journal Article
Open access
RRRedwan Rahmat
Redwan Rahmat
MRMatthijs F. Ravensberg
Matthijs F. Ravensberg
DSDebby Schipper
Debby Schipper
KKKeshia Kroh
Keshia Kroh
EKEdwin J.B. Veldhuis Kroeze
Edwin J.B. Veldhuis Kroeze
CECarmen Embregts
Carmen Embregts
Rabies is a fatal zoonosis that impairs host immune function, yet effects on peripheral lymphoid architecture are poorly defined. During a 2021–2022 rabies virus (RABV) outbreak in South Africa, we collected cervical lymph nodes from 36 rabies-suspect dogs; RABV RNA was detected in 27. Canine distemper virus RNA was detected in a subset across both RABV-positive (RABV+) and RABV-negative (RABV−) groups and was not associated with clinical-sign count. We set up a computer-assisted histological analysis tool to quantify germinal-centre (GC) nucleus density and immunohistochemistry for CD20, PNA and IBA1 to profile B cells, GC activity and macrophages. Within the outbreak cohort, GC density and marker-based metrics did not differ between RABV+ and RABV− dogs. Two healthy dogs were included as reference tissues; values in outbreak dogs were generally lower, but these contrasts are contextual given the limited, non-matched controls. This study provides a reproducible framework for quantifying immune cell organization in field-collected tissues during natural RABV exposure and highlights the need for larger, geographically matched control groups and complementary functional immune measurements.

17 September 2026 in Journal of General Virology
Verified
Journal Article
Open access
KKKeshia Kroh
Keshia Kroh
LHLeanne C. Helgers
Leanne C. Helgers
TGTeunis B. H. Geijtenbeek
Teunis B. H. Geijtenbeek
CECarmen W. E. Embregts
Carmen W. E. Embregts
CGCorine H. GeurtsvanKessel
Corine H. GeurtsvanKessel
Rabies virus (RABV) is a neurotropic virus of the genus Lyssavirus that causes a nearly always fatal encephalitis in humans once it reaches the central nervous system. Dog bites are a major transmission route of RABV, and following superficial skin exposure, RABV first encounters epidermal Langerhans cells (LCs), yet their role in early infection remains poorly understood. Here, we show that exposure of immature human epidermal LCs to RABV leads to RABV association with cells in the absence of productive viral replication. RABV-exposed LCs display reduced cytokine and type I IFN responses and lack induction of IFN-stimulated genes, indicating suppression of antiviral signalling pathways. Together, these findings suggest that RABV is efficiently taken up by immature LCs, which dampens the antiviral immune responses of LCs, potentially facilitating immune evasion at the skin entry site.